Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × CYT003-QbG10 × Clear all

NCT05445609 2025-09-19

Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 2 Suspended

Prostatic Neoplasms